Takaaki Tokito Selected Research

Takaaki Tokito Research Topics

Disease

45	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 06/2013
21	Neoplasms (Cancer) 10/2023 - 06/2013
7	Pneumonia (Pneumonitis) 04/2024 - 11/2017
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2024 - 03/2010
7	Disease Progression 01/2023 - 09/2016
6	Lung Neoplasms (Lung Cancer) 04/2024 - 09/2016
5	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2023 - 12/2020
5	Neoplasm Metastasis (Metastasis) 12/2020 - 03/2010
3	Adenocarcinoma of Lung 10/2022 - 10/2015
3	Adenocarcinoma 12/2020 - 01/2018
2	Cytokine Release Syndrome 11/2023 - 10/2022
2	Fever (Fevers) 11/2023 - 10/2022
2	Cachexia 10/2023 - 01/2023
2	Infections 10/2022 - 05/2014
2	Diarrhea 10/2022 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 12/2020 - 12/2019
2	Neutropenia 12/2019 - 03/2014
2	Body Weight (Weight, Body) 12/2018 - 11/2017
1	Idiopathic Pulmonary Fibrosis 02/2024
1	Febrile Neutropenia 10/2023
1	Adenoid Cystic Carcinoma (Cylindroma) 10/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2023
1	Cysts 01/2023
1	Bronchiectasis 01/2023
1	Dyspnea (Shortness of Breath) 11/2022
1	Rhabdomyosarcoma 11/2022
1	COVID-19 10/2022
1	Heart Arrest (Cardiac Arrest) 10/2022
1	Idiopathic Interstitial Pneumonias 01/2022
1	Colitis 08/2018
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2017
1	Pancytopenia 10/2017
1	Gastrointestinal Hemorrhage (Hematochezia) 10/2015
1	Ulcerative Colitis 10/2015

Drug/Important Bio-Agent (IBA)

13	Immune Checkpoint InhibitorsIBA 10/2023 - 08/2018
11	PlatinumIBA 02/2024 - 06/2013
8	Carboplatin (JM8)FDA LinkGeneric 04/2024 - 10/2015
8	Pemetrexed (MTA)FDA Link 01/2023 - 03/2014
7	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2018
5	Tyrosine Kinase InhibitorsIBA 04/2024 - 01/2018
5	NivolumabIBA 04/2024 - 08/2018
5	Etoposide (VP 16)FDA LinkGeneric 04/2024 - 02/2014
5	pembrolizumabIBA 02/2024 - 01/2021
5	AfatinibIBA 01/2023 - 01/2018
5	Bevacizumab (Avastin)FDA Link 01/2021 - 06/2013
4	osimertinibIBA 04/2024 - 01/2020
4	durvalumabIBA 04/2024 - 11/2017
3	IpilimumabIBA 04/2024 - 10/2022
3	RamucirumabIBA 10/2023 - 12/2019
3	Docetaxel (Taxotere)FDA Link 10/2023 - 12/2018
3	130-nm albumin-bound paclitaxelIBA 04/2023 - 01/2020
3	atezolizumabIBA 01/2022 - 12/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 03/2010
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 03/2014
3	LigandsIBA 09/2017 - 03/2015
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2023
2	SolutionsIBA 03/2022 - 01/2020
2	B7-H1 AntigenIBA 01/2021 - 11/2017
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 03/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015 - 06/2013
1	tepotinibIBA 02/2024
1	nintedanibIBA 02/2024
1	C-Reactive ProteinIBA 10/2023
1	GhrelinIBA 10/2023
1	OsteopontinIBA 10/2023
1	CytokinesIBA 01/2023
1	pazopanib FDA Link 11/2022
1	eribulin FDA Link 11/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022
1	Amino Acids FDA Link 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	amrubicinIBA 01/2021
1	Circulating Tumor DNAIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2019
1	Tumor Biomarkers (Tumor Markers)IBA 05/2019
1	Carcinoembryonic AntigenIBA 05/2019
1	Keratins (Keratin)IBA 05/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 10/2015
1	Monoclonal AntibodiesIBA 10/2015

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 02/2024 - 03/2010
15	Therapeutics 04/2024 - 06/2013
6	Chemoradiotherapy 04/2024 - 03/2016
6	Aftercare (After-Treatment) 11/2023 - 10/2015
4	Immunotherapy 10/2023 - 10/2022
2	Lymph Node Excision (Lymph Node Dissection) 12/2020 - 12/2019
2	Gastrectomy 12/2020 - 12/2019
1	Proton Therapy 10/2023
1	Traction 01/2023
1	Critical Care (Surgical Intensive Care) 10/2022
1	Hepatectomy 12/2020
1	Gastroenterostomy 12/2020
1	Withholding Treatment 12/2020
1	Radiotherapy 11/2017
1	Adjuvant Chemotherapy 09/2017
1	Bronchoscopes 01/2017
1	Duration of Therapy 11/2016